[ET Net News Agency, 29 March 2023] CLOVER BIO-B (02197) fell 10.38% to HK$1.64.
It hits an intra-day low of HK$1.59, hitting a historical low, and an intra-day high of
HK$1.87. The total shares traded was 13.82 million, with a value of HK$23.62m. The active
buy/sell ratio is 47:53, with net selling turnover of HK$1.55m. CHINA INV INFO accounts
for greatest net responsive buying turnover of HK$2.13m, with volume weighted average
price of HK$1.741. CHINA INNOVATION MARKET SER accounts for greatest net responsive
selling turnover of HK$3.17m, with volume weighted average price of HK$1.697. The stock
has fallen a combined 16.75% over the past 6 consecutive trading days.
Basic Information
=================
----------------------------------
Nominal 1.640 % Chg -10.38%
High 1.870 Low 1.590
Shares Tr 13.82m Turnover 23.62m
10-D SMA 1.908 %H.V 40.129
20-D SMA 2.093 VWAP 1.709
50-D SMA 2.412 RSI14 21.915
----------------------------------
Status: Hitting a historical low, active buy/sell ratio is 47:53, with net selling
turnover of HK$1.55m, falling a combined 16.75% over the past 6 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CLOVER BIO-B (02197) 1.64 -10.38
EVEREST MED-B (01952) 15.30 +1.32
BRII-B (02137) 4.54 -0.22
KEYMED BIO-B (02162) 57.05 +2.98
NH HEALTH (06606) 28.00 -0.71
ASCENTAGE-B (06855) 23.45 -2.90
AKESO (09926) 40.65 -0.37
KINTOR PHARMA-B (09939) 7.50 +0.40
ALPHAMAB-B (09966) 13.56 -2.87
REMEGEN-B (09995) 43.75 +0.92
-----------------------------------------------
(ed)